Decipher Bladder Cancer Test for Patients

Decipher Bladder gives clear, meaningful information to help you and your doctor choose the treatment plan that’s right for you.

Understand the Report Insurance Coverage
Cancer area illustration

Why would my doctor order the Decipher Bladder test?

Your doctor may order Decipher Bladder because it provides insights into your cancer, helping understand its aggressiveness, whether it may progress and which treatments may be most appropriate for you.

Inherited Risk Assessment
Screening and Risk Assessment
Diagnosis
Prognosis
Treatment Guidance
Recurrence Monitoring
Cost and Coverage View Sample Report View FAQs

Talk to your doctor about whether Veracyte tests might be right for you.

How does the test work?

Decipher Bladder is a genomic test that helps inform treatment decisions following a bladder cancer diagnosis.

A young female health care provider with glasses and a stethoscope, smiling and holding papers, converses with a patient in a bright office. The setting feels professional and welcoming.

Decipher Bladder is for patients diagnosed with non-muscle invasive or muscle invasive bladder cancer (clinical stage T1-T4a).

A scientist in a lab coat uses a pipette in a laboratory. The setting is organized and focused, highlighting concentration and precision.

Your Decipher Bladder results group your tumor into one of two main molecular subtype categories:

  • Luminal subtypes are associated with less aggressive disease, lower risk of disease spread, and distinct responses to certain treatments.
  • Non-luminal subtypes are associated with more aggressive disease, higher risk of disease spread, and a greater likelihood of benefit from treatments like chemotherapy or immunotherapy in some patients.
A surgeon in a blue surgical mask and cap focuses intently, with gloved hands raised. The close-up conveys concentration and precision.

The Decipher test is performed on tumor tissue taken during a transurethral resection of bladder tumor (TURBT).

No additional medical procedure is required. 

A smiling health care provider in a white coat and stethoscope consults with an older patient, creating a warm, caring atmosphere in a bright medical office.

Your doctor receives your Decipher test results in a report tailored to your clinical scenario. They will review the report with you and discuss how it may guide your treatment.

Is the Decipher Bladder test covered by insurance?

We are committed to making Decipher Bladder accessible to all eligible patients. Medicare provides coverage and we offer financial assistance and flexible payment options for commercial and self-pay patients.

Medicare

Decipher Bladder is covered by Medicare for patients with clinical stage T1-T4a bladder cancer. View full coverage criteria on the Centers for Medicare and Medicaid Services LCD L38649.



For more information, contact us.

Stage GroupingAJCC StageMedicare Coverage
Ta, N0, M0
0a
Tis (CIS), N0, M0
0is
T1, N0, M0
I
T2a/T2b, N0, M0
II
T3a/T3b/T4a, N0, M0
or T1-4a, N1, M0
IIIA
T1-T4a, N2/N3, M0
IIIB
T4b, Any N, M0
IVA
Any T, Any N, M1b
IVB

Financial assistance

In the event the Decipher Bladder test is not covered by your commercial insurance, you may qualify for financial assistance or a tailored payment plan through the Veracyte Access Program. Restrictions apply.

  1. Financial assistance eligibility depends on your household income and insurance status.
  2. Payment plans are available to accommodate certain financial situations to ensure affordability for patients.

Have questions about financial assistance? We’re here to help. Contact us today.

People in Home$0 cost
to patient if income is less than:
$100 cost
to patient if income is less than:
$295 cost
to patient if income is less than:
1
$46,950
$54,775
$62,600
2
$63,450
$74,025
$84,600
3
$79,950
$93,275
$106,600
4
$96,450
$112,525
$128,600
5
$112,950
$131,775
$150,600

Understanding your test result

The Decipher Bladder report provides the molecular subtype of your tumor and language that helps interpret:

  • How the subtype impacts disease prognosis
  • Likelihood of upstaging
  • Benefit from receiving neoadjuvant chemotherapy (NAC)
Download Brochure Download Sample Report

Frequently Asked Questions

View All FAQs

Keep exploring

Patient Resource Center

Helpful resources to support your cancer journey.

Explore

Blog

Inspiring stories and latest clinical advances.

Learn More

Patient payment portal

Sign into your account today for quick, easy payments.

Pay My Bill

Connect with us

Contact Us

Disclaimers

Decipher testing is available in the United States as part of Veracyte’s CLIA-validated laboratory developed test (LDT) service, and FDA clearance is not required.

Talk to your doctor about whether Veracyte tests might be right for you.

Veracyte Access eligibility is based on total annual household income, insurance status, and household size. Some eligibility restrictions apply. Veracyte offers certain Decipher tests at a reduced cost to eligible applicants except where otherwise restricted. Residents of the United States, District of Columbia and Puerto Rico are eligible to apply. Veracyte Access does not constitute health insurance. You must meet certain income requirements set forth above. We may request documentation to verify your income, including recently filed tax returns and other supporting documentation. By requesting assistance, you certify, to the best of your knowledge, that you are eligible for assistance and that you have insufficient financial resources to pay for the ordered test. We may discontinue or change this program at any time for any reason without notice.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.